Literature DB >> 16855492

Stepwise treatment paradigm for congenital nasolacrimal duct obstruction.

Douglas R Casady1, Dale R Meyer, John W Simon, George O Stasior, Jitka L Zobal-Ratner.   

Abstract

PURPOSE: To compare the outcomes achieved by a series of patients treated in a stepwise fashion who presented with congenital nasolacrimal duct obstruction.
METHODS: In this retrospective interventional case series, 127 patients, ranging in age from 1 month to 81 months, with 173 lacrimal systems diagnosed with congenital nasolacrimal duct obstruction, were treated in a stepwise fashion. A treatment paradigm was evaluated that prescribed probing as an initial procedure regardless of age. Those who failed probing received balloon catheter dilation. Those who failed probing and balloon catheterization received silicone intubation. Dacryocystorhinostomy was reserved for patients failing the above treatments. Clinical success was defined as complete resolution of symptoms. Success rates at each step were evaluated, and a cost analysis was performed.
RESULTS: Lacrimal probing was successful in 134 of 173 (76.9%) cases. Of the 39 probing failures, 32 (82.1%) were cured with balloon catheterization. All 7 cases (100%) that failed probing and balloon catheterization were cured with silicone intubation. No patient in this series required dacryocystorhinostomy.
CONCLUSIONS: A stepwise approach to the treatment of congenital nasolacrimal duct obstruction is a clinically and financially effective model for treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16855492     DOI: 10.1097/01.iop.0000225750.25592.7f

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  17 in total

1.  Long-term results of probing guided with soft cannula in children with congenital nasolacrimal duct obstruction.

Authors:  Dilek Yuksel; Pınar Altiaylik Ozer
Journal:  Jpn J Ophthalmol       Date:  2013-11-16       Impact factor: 2.447

2.  [Increased prevalence of congenital dacryostenosis following cesarean section].

Authors:  Claudia Kuhli-Hattenbach; M Lüchtenberg; C Hofmann; T Kohnen
Journal:  Ophthalmologe       Date:  2016-08       Impact factor: 1.059

3.  Office probing for treatment of nasolacrimal duct obstruction in infants.

Authors:  Aaron M Miller; Danielle L Chandler; Michael X Repka; Darren L Hoover; Katherine A Lee; Michele Melia; Paul J Rychwalski; David I Silbert; Roy W Beck; Eric R Crouch; Sean Donahue; Jonathan M Holmes; Graham E Quinn; Nick A Sala; Susan Schloff; David K Wallace; Nicole C Foster; Kevin D Frick; Richard P Golden; Scott R Lambert; D Robbins Tien; David R Weakley
Journal:  J AAPOS       Date:  2014-02       Impact factor: 1.220

4.  A comparison between monocanalicular and pushed monocanalicular silicone intubation in the treatment of congenital nasolacrimal duct obstruction.

Authors:  Dima Andalib; Hossein Mansoori
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

5.  Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years.

Authors:  Michael X Repka; Danielle L Chandler; Roy W Beck; Eric R Crouch; Sean Donahue; Jonathan M Holmes; Katherine Lee; Michele Melia; Graham E Quinn; Nick A Sala; Susan Schloff; David I Silbert; David K Wallace
Journal:  Ophthalmology       Date:  2007-11-08       Impact factor: 12.079

6.  Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age.

Authors:  Michael X Repka; B Michele Melia; Roy W Beck; Danielle L Chandler; Deborah R Fishman; Todd A Goldblum; Jonathan M Holmes; Bernard D Perla; Graham E Quinn; David I Silbert; David K Wallace
Journal:  J AAPOS       Date:  2008-10       Impact factor: 1.220

7.  Value of microbiology study in congenital nasolacrimal duct obstruction.

Authors:  Yasser H Al-Faky; Tahir Naeem; Nora Al-Sobaie; Reem Al-Huthail; Hessa Al-Odan; Essam A Osman; Ahmad Mousa
Journal:  Saudi J Ophthalmol       Date:  2012-03-10

8.  Efficacy of probing for children with congenital nasolacrimal duct obstruction: a retrospective study using fluorescein dye disappearance test and lacrimal sac echography.

Authors:  Piero Steindler; Enrico Mantovani; Carlo Incorvaia; Francesco Parmeggiani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-24       Impact factor: 3.117

9.  Balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing.

Authors:  Michael X Repka; Danielle L Chandler; Jonathan M Holmes; Darren L Hoover; Christine L Morse; Susan Schloff; David I Silbert; D Robbins Tien
Journal:  Arch Ophthalmol       Date:  2009-05

10.  Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction.

Authors:  Paul O Phelps; Samuel A Abariga; Benjamin J Cowling; Dinesh Selva; Marcus M Marcet
Journal:  Cochrane Database Syst Rev       Date:  2020-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.